Ewgeni Jakubovski
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Ewgeni Jakubovski has a total of 15 co-authors. Here are the top co-authors by number of shared publications:
- Albina Rodrigues Torres
Department of Neurology, Psychology and Psychiatry, Botucatu Medical School, Univ Estadual Paulista (UNESP), Brazil
1 shared publication Carolina Valerio
Department of Psychiatry; University of Sao Paulo School of Medicine; Sao Paulo; Sao Paulo; Brazil
1 shared publication- Christopher Pittenger
Department of Psychiatry, Yale University, New Haven, USA
1 shared publication Clarice Gorenstein
University of São Paulo Department of Pharmacology Institute of Biomedical Sciences São Paulo São Paulo Brazil
1 shared publicationCristina Belotto-Silva
Department of Psychiatry; University of Sao Paulo School of Medicine; Sao Paulo; Sao Paulo; Brazil
1 shared publicationEuripedes Constantino Miguel
Department of Psychiatry, Faculdade de Medicina da Universidade de São Paulo
1 shared publication
Latest Publications
- 25 October 2012
- Published by Hindawi Limited in Depression and Anxiety
- Vol. 30 (8) , 763-772
CLINICAL PREDICTORS OF LONG-TERM OUTCOME IN OBSESSIVE-COMPULSIVE DISORDER
Background The purpose of this study was to investigate demographic and clinical factors associated with the long‐term outcome of obsessive‐compulsive disorder (OCD). Methods A hundred ninety‐six previously untreated patients with DSM‐IV criteria OCD completed a 12‐week randomized open trial of group cognitive‐behavioral therapy (GCBT) or fluoxetine, followed by 21 months of individualized, uncontrolled treatment, according to international guidelines for OCD treatment. OCD severity was assessed using the Yale–Brown Obsessive‐Compulsive Scale (Y‐BOCS) at different times over the follow‐up period. Demographics and several clinical variables were assessed at baseline. Results Fifty percent of subjects improved at least 35% from baseline, and 21.3% responded fully (final Y‐BOCS score < or = 8). Worse prognosis was associated with earlier age at onset of OCD (P = 0.045), longer duration of illness (P = 0.001) presence of at least one comorbid psychiatric disorder (P = 0.001), comorbidity with a mood disorder (P = 0.002), higher baseline Beck‐Depression scores (P = 0.011), positive family history of tics (P = 0.008), and positive family history of anxiety disorders (P = 0.008). Type of initial treatment was not associated with long‐term outcome. After correction for multiple testing, the presence of at least one comorbid disorder, the presence of a depressive disorder, and duration of OCD remained significant. Conclusions Patients under cognitive‐behavioral or pharmacological treatment improved continuously in the long run, regardless of initial treatment modality or degree of early response, suggesting that OCD patients benefit from continuous treatment. Psychiatric comorbidity, especially depressive disorders, may impair the long‐term outcome of OCD patients.
- 25 October 2012
- Published by Hindawi Limited in Depression and Anxiety
- Vol. 30 (8) , 763-772
CLINICAL PREDICTORS OF LONG-TERM OUTCOME IN OBSESSIVE-COMPULSIVE DISORDER
Background The purpose of this study was to investigate demographic and clinical factors associated with the long‐term outcome of obsessive‐compulsive disorder (OCD). Methods A hundred ninety‐six previously untreated patients with DSM‐IV criteria OCD completed a 12‐week randomized open trial of group cognitive‐behavioral therapy (GCBT) or fluoxetine, followed by 21 months of individualized, uncontrolled treatment, according to international guidelines for OCD treatment. OCD severity was assessed using the Yale–Brown Obsessive‐Compulsive Scale (Y‐BOCS) at different times over the follow‐up period. Demographics and several clinical variables were assessed at baseline. Results Fifty percent of subjects improved at least 35% from baseline, and 21.3% responded fully (final Y‐BOCS score < or = 8). Worse prognosis was associated with earlier age at onset of OCD (P = 0.045), longer duration of illness (P = 0.001) presence of at least one comorbid psychiatric disorder (P = 0.001), comorbidity with a mood disorder (P = 0.002), higher baseline Beck‐Depression scores (P = 0.011), positive family history of tics (P = 0.008), and positive family history of anxiety disorders (P = 0.008). Type of initial treatment was not associated with long‐term outcome. After correction for multiple testing, the presence of at least one comorbid disorder, the presence of a depressive disorder, and duration of OCD remained significant. Conclusions Patients under cognitive‐behavioral or pharmacological treatment improved continuously in the long run, regardless of initial treatment modality or degree of early response, suggesting that OCD patients benefit from continuous treatment. Psychiatric comorbidity, especially depressive disorders, may impair the long‐term outcome of OCD patients.
- 1 August 2011
- Published by Elsevier in Progress in Neuro-Psychopharmacology and Biological Psychiatry
- Vol. 35 (7) , 1677-1681
Dimensional correlates of poor insight in obsessive–compulsive disorder
- 1 August 2011
- Published by Elsevier in Progress in Neuro-Psychopharmacology and Biological Psychiatry
- Vol. 35 (7) , 1677-1681
Dimensional correlates of poor insight in obsessive–compulsive disorder